Atlas FDA

EXABLATE 2000 SYSTEM

FDA premarket approval P040003 · decided 2004-10-22

Approval details

PMA number
P040003
Trade name
EXABLATE 2000 SYSTEM
Generic name
Ablation system, high intensity focused ultrasound (HIFU), MR-guided
Applicant
Insightec, Ltd.
Date received
2004-01-27
Decision date
2004-10-22
Days to decision
269 days
Decision code
APPR
Product code
NRZ
Advisory committee
Obstetrics/Gynecology
Expedited review
Yes
Location
Dallas, TX
Statement
APPROVAL FOR THE EXABLATE 2000 SYSTEM. THE DEVICE IS INDICATED FOR ABLATION OF UTERINE FIBROID TISSUE IN PRE-OR PERI-MENOPAUSAL WOMEN WITH SYMPTOMATIC UTERINE FIBROIDS WHO DESIRE A UTERINE SPARING PROCEDURE. PATIENTS MUST HAVE A UTERINE SIZE OF LESS THAN 24 WEEKS AND HAVE COMPLETED CHILD BEARING.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Exablate Model 2100V1, Exablate Prostate System, Exablate MRgFUS, Exablate 2100V1 Type 3.0 (K231378)Insightec, Ltd.2023-10-30